Ind-Swift Laboratories Ltd (INDSWFTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 393806,
    "name": "Ind-Swift Labs.",
    "stock_name": "Ind-Swift Labs.",
    "full_name": "Ind-Swift Laboratories Ltd",
    "name_url": "stocks-analysis/ind-swift-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "168.30",
    "chg": 5.8,
    "chgp": "3.57%",
    "dir": 1,
    "prev_price": "162.50",
    "mcapval": "1,448.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532305,
    "symbol": "INDSWFTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE915B01019",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "16.36 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-sell-4000720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndSwiftLaborat_mojoScore_4000720.png",
        "date": "2026-05-20 10:10:56",
        "description": "Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-sell-3982766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndSwiftLaborat_mojoScore_3982766.png",
        "date": "2026-05-09 10:10:25",
        "description": "Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-sell-3982757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndSwiftLaborat_mojoScore_3982757.png",
        "date": "2026-05-09 10:10:25",
        "description": "Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ind-Swift Laboratories Gains 3.98%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-398-4-key-factors-driving-the-week-3962819",
        "imagepath": "",
        "date": "2026-04-25 17:10:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Downgrade to Sell amid mixed financial signals</p>\n                    <p><strong>22 Apr:</strong> Bullish momentum observed despite mixed technical indicators</p>\n                    <p><strong>23 Apr:</strong> Upgrade to Hold following technical and financial improvements</p>\n                    <p><strong>24 Apr:</strong> Technical momentum shifts to mildly bullish amid mixed signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.132.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3960053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_technicaldot_3960053.png",
        "date": "2026-04-24 08:00:56",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term metrics suggest a cautiously optimistic outlook, prompting a reassessment of its technical stance from Sell to Hold."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-signals-3953345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3953345.png",
        "date": "2026-04-20 08:10:26",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation concerns have weighed heavily on the decision, reflected in a MarketsMOJO Mojo Score of 44.0 and a Sell grade. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3943347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3943347.png",
        "date": "2026-04-12 10:10:33",
        "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 156.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1565-3939136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_priceRelatedfactors_3939136.png",
        "date": "2026-04-09 09:40:37",
        "description": "With a remarkable 82.7% gain over the past year, Ind-Swift Laboratories Ltd has surged to a fresh 52-week high of Rs 156.5 on 9 Apr 2026, significantly outperforming the Sensex's modest 4.4% rise. This milestone underscores the stock's sustained momentum amid a broader market that is currently under pressure."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 154.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1547-3938009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_priceRelatedfactors_3938009.png",
        "date": "2026-04-08 15:35:04",
        "description": "With a decisive surge to Rs 154.7 on 8 Apr 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking an impressive 82.96% gain over the past year. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of the Sensex’s modest 4.49% rise during the same period."
      }
    ],
    "total": 15,
    "sid": "393806",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ind-swift-laboratories-393806"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "28-May-2026",
      "details": "Intimation of allotment of 125000 equity shares pursuant to ESOP 2014.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026",
      "datetime": "28-May-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11",
          "dt": "2011-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ind-Swift Laboratories Ltd is Rated Sell

2026-05-20 10:10:56

Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with the latest insights into the company's performance and outlook.

Ind-Swift Laboratories Ltd is Rated Sell

2026-05-09 10:10:25

Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Ind-Swift Laboratories Ltd is Rated Sell

2026-05-09 10:10:25

Ind-Swift Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Ind-Swift Laboratories Gains 3.98%: 4 Key Factors Driving the Week

2026-04-25 17:10:30

Key Events This Week 20 Apr: Downgrade to Sell amid mixed financial signals 22 Apr: Bullish momentum observed despite mixed technical indicators 23 Apr: Upgrade to Hold following technical and financial improvements 24 Apr: Technical momentum shifts to mildly bullish amid mixed signals Week OpenRs.132.10 Week Close<di...

Ind-Swift Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-24 08:00:56

Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term metrics suggest a cautiously optimistic outlook, prompting a reassessment of its technical stance from Sell to Hold.

Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial Signals

2026-04-20 08:10:26

Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation concerns have weighed heavily on the decision, reflected in a MarketsMOJO Mojo Score of 44.0 and a Sell grade. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change.

Ind-Swift Laboratories Ltd is Rated Hold

2026-04-12 10:10:33

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 156.5

2026-04-09 09:40:37

With a remarkable 82.7% gain over the past year, Ind-Swift Laboratories Ltd has surged to a fresh 52-week high of Rs 156.5 on 9 Apr 2026, significantly outperforming the Sensex's modest 4.4% rise. This milestone underscores the stock's sustained momentum amid a broader market that is currently under pressure.

Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 154.7

2026-04-08 15:35:04

With a decisive surge to Rs 154.7 on 8 Apr 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking an impressive 82.96% gain over the past year. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of the Sensex’s modest 4.49% rise during the same period.

View All News